Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-062130
Filing Date
2025-06-24
Accepted
2025-06-24 16:37:26
Documents
1
Period of Report
2025-06-20

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2518795-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2518795-1_4seq1.xml 4 4912
  Complete submission text file 0001104659-25-062130.txt   6380
Mailing Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494 (781) 292-4200
Verastem, Inc. (Issuer) CIK: 0001526119 (see all company filings)

EIN.: 273269467 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O VERASTEM, INC. 117 KENDRICK STREET, SUITE 500 NEEDHAM MA 02494
Business Address
Calkins Daniel (Reporting) CIK: 0001951861 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35403 | Film No.: 251069705